PRESS RELEASE published on 10/12/2023 at 12:45, 2 years 6 months ago NanoViricides, Inc. to Present at the Partnership Opportunities in Drug Delivery Conference in Boston on October 16, 2023 at 6:07pm ET
PRESS RELEASE published on 08/21/2023 at 12:45, 2 years 8 months ago The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, is Progressing Successfully, Reports NanoViricides
PRESS RELEASE published on 07/11/2023 at 12:45, 2 years 9 months ago Company’s Broad-Spectrum Antiviral NV-387 Has Demonstrated Excellent Effectiveness in RSV in a Lethal Lung Disease Animal Model, Reports NanoViricides
PRESS RELEASE published on 07/06/2023 at 12:45, 2 years 9 months ago Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs
PRESS RELEASE published on 06/29/2023 at 12:45, 2 years 10 months ago NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
PRESS RELEASE published on 05/31/2023 at 12:40, 2 years 11 months ago NanoViricides, Inc. to Present at the BIO International Convention in Boston on June 5th, 2023 at 3:15pm ET
PRESS RELEASE published on 05/16/2023 at 12:45, 2 years 11 months ago NanoViricides Has Filed its Quarterly Report - Clinical Trials of Broad-Spectrum COVID Drug About to Begin
PRESS RELEASE published on 04/25/2023 at 12:45, 3 years ago NanoViricides is Expanding its Broad-Spectrum Antiviral Program to Explore Further Antiviral Applications of its COVID Clinical Drug Ingredient
PRESS RELEASE published on 04/17/2023 at 12:45, 3 years ago NanoViricides Has Shipped Drug Products for Impending Clinical Trials of NV-CoV-2, Its COVID Drug Candidate
PRESS RELEASE published on 04/04/2023 at 13:45, 3 years 1 month ago NanoViricides Signs a License Agreement That Includes Clinical Evaluation of Its COVID-19 Drug Candidates
Published on 05/06/2026 at 02:17, 6 hours 23 minutes ago Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 02:00, 6 hours 40 minutes ago Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Published on 05/06/2026 at 02:00, 6 hours 40 minutes ago Alset AI Announces Shares for Debt Transaction
Published on 05/06/2026 at 01:30, 7 hours 10 minutes ago Presentation to RIU Sydney Resources Roundup
Published on 05/06/2026 at 01:20, 7 hours 20 minutes ago Empress Grants Stock Options and Equity Incentives
Published on 05/06/2026 at 08:30, 10 minutes ago Finexity AG: FINEXITY Group resolves capital increase with subscription rights – access extended to all investors via FINEXITY Access
Published on 05/06/2026 at 08:13, 26 minutes ago “European leadership depends on integration, scale, and protection of strategic industries”
Published on 05/06/2026 at 08:10, 29 minutes ago KISTERS launches HyQuant Edge: The first radar sensor-based monitoring station for quantitative hydrology
Published on 05/06/2026 at 08:00, 39 minutes ago Ørsted delivers progress and strong operational performance
Published on 05/05/2026 at 19:00, 13 hours 40 minutes ago Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 18:03, 14 hours 36 minutes ago Aéroports de Paris SA - Shares and voting rights as of 30 April 2026
Published on 05/05/2026 at 17:53, 14 hours 46 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - April 2026
